Welcome members and clients of OMMP PIF. Due to increased costs, our website has moved to this server, Thanks go to our Friend and colleague, Wired57, for making this possible. If you have any questions or concerns, please start a new topic in 
Thank you 
12-07-2016, 12:16 AM
A Randomized, Controlled Trial of Cannabis in Healthy Volunteers Evaluating Simulated Driving, Field Performance Tests and Cannabinoid LevelsINVESTIGATORS: Thomas Marcotte, Ph.D. & Barth Wilsey, M.D.
STUDY LOCATION: University of California, San Diego
PROJECT TITLE: A Randomized, Controlled Trial of Cannabis in Healthy Volunteers Evaluating Simulated Driving, Field Performance Tests and Cannabinoid Levels
PROJECT TYPE: Clinical Study
STATUS: PENDING
ABSTRACT:
This study was authorized by the California Legislature (Assembly Bill 266, the Medical Marijuana Regulation and Safety Act) to help with detection of driving under the influence of cannabis. Healthy volunteers will inhale smoked cannabis with either 0% (placebo), 6.7%, or 12.6% 9-THC at the beginning of the day, and then complete driving simulations, iPad-based performance assessments,,......
<a data-ipb="nomediaparse" href="http://www.cmcr.ucsd.edu/index.php/2015-11-20-20-52-15/pending-studies/62-ab266">http://www.cmcr.ucsd.edu/index.php/2015-11-20-20-52-15/pending-studies/62-ab266</a>
-----------------------------------------------------------------------------------------------------------------------------
A Randomized, Cross-Over Controlled Trial of Dronabinol and Vaporized Cannabis in Neuropathic Low Back PainINVESTIGATORS: Barth Wilsey, M.D. & Thomas Marcotte, Ph.D.
STUDY LOCATION: University of California, San Diego
PROJECT TITLE: A Randomized, Cross-Over Controlled Trial of Dronabinol and Vaporized Cannabis in Neuropathic Low Back Pain
PROJECT TYPE: Clinical Study
STATUS: PENDING
ABSTRACT:
This study will involve treating low back pain associated with nerve injury with oral delta-9-tetrahydrocannabinol (9-THC) or whole plant cannabis for eight weeks. Research subjects will consume either oral 9-THC (dronabinol), vaporized 3.5% 9-THC, or placebo. The major objective of the present study is to demonstrate an analgesic response to oral and/or inhaled cannabis in patients with neuropathic low back pain.
The primary outcome will be a pain intensity numerical rating scale bordered by 0=no pain and 10=worst possible pain. As a major goal in the development of cannabinoid-based medications is the separation of pain relief from side-effects, numerous other assessments will also be performed. Neuropsychological testing with the Digit Symbol Modalities Test (attention), the Hopkins Verbal Learning,........
<a data-ipb="nomediaparse" href="http://www.cmcr.ucsd.edu/index.php/2015-11-20-20-52-15/pending-studies/16-a-randomized-cross-over-controlled-trial-of-dronabinol-and-vaporized-cannabis-in-neuropathic-low-back-pain">http://www.cmcr.ucsd.edu/index.php/2015-11-20-20-52-15/pending-studies/16-a-randomized-cross-over-controlled-trial-of-dronabinol-and-vaporized-cannabis-in-neuropathic-low-back-pain</a>
STUDY LOCATION: University of California, San Diego
PROJECT TITLE: A Randomized, Controlled Trial of Cannabis in Healthy Volunteers Evaluating Simulated Driving, Field Performance Tests and Cannabinoid Levels
PROJECT TYPE: Clinical Study
STATUS: PENDING
ABSTRACT:
This study was authorized by the California Legislature (Assembly Bill 266, the Medical Marijuana Regulation and Safety Act) to help with detection of driving under the influence of cannabis. Healthy volunteers will inhale smoked cannabis with either 0% (placebo), 6.7%, or 12.6% 9-THC at the beginning of the day, and then complete driving simulations, iPad-based performance assessments,,......
<a data-ipb="nomediaparse" href="http://www.cmcr.ucsd.edu/index.php/2015-11-20-20-52-15/pending-studies/62-ab266">http://www.cmcr.ucsd.edu/index.php/2015-11-20-20-52-15/pending-studies/62-ab266</a>
-----------------------------------------------------------------------------------------------------------------------------
A Randomized, Cross-Over Controlled Trial of Dronabinol and Vaporized Cannabis in Neuropathic Low Back PainINVESTIGATORS: Barth Wilsey, M.D. & Thomas Marcotte, Ph.D.
STUDY LOCATION: University of California, San Diego
PROJECT TITLE: A Randomized, Cross-Over Controlled Trial of Dronabinol and Vaporized Cannabis in Neuropathic Low Back Pain
PROJECT TYPE: Clinical Study
STATUS: PENDING
ABSTRACT:
This study will involve treating low back pain associated with nerve injury with oral delta-9-tetrahydrocannabinol (9-THC) or whole plant cannabis for eight weeks. Research subjects will consume either oral 9-THC (dronabinol), vaporized 3.5% 9-THC, or placebo. The major objective of the present study is to demonstrate an analgesic response to oral and/or inhaled cannabis in patients with neuropathic low back pain.
The primary outcome will be a pain intensity numerical rating scale bordered by 0=no pain and 10=worst possible pain. As a major goal in the development of cannabinoid-based medications is the separation of pain relief from side-effects, numerous other assessments will also be performed. Neuropsychological testing with the Digit Symbol Modalities Test (attention), the Hopkins Verbal Learning,........
<a data-ipb="nomediaparse" href="http://www.cmcr.ucsd.edu/index.php/2015-11-20-20-52-15/pending-studies/16-a-randomized-cross-over-controlled-trial-of-dronabinol-and-vaporized-cannabis-in-neuropathic-low-back-pain">http://www.cmcr.ucsd.edu/index.php/2015-11-20-20-52-15/pending-studies/16-a-randomized-cross-over-controlled-trial-of-dronabinol-and-vaporized-cannabis-in-neuropathic-low-back-pain</a>